Daniel Figeys is co-founder of MedBiome Inc. He is also a Professor and Distinguished Research Chair in the Faculty of Medicine at the University of Ottawa. Daniel obtained a B.Sc. and a M.Sc. in chemistry from the Université de Montréal. He obtained a Ph.D. in Chemistry from the University of Alberta and did his postdoctoral studies at the University of Washington. Prior to his current position, Dr. Daniel Figeys was Senior VP of Systems Biology and Lead Profiling with MDS-Proteomics/Ocata. From 1998 to 2000, Dr. Figeys was a Research Officer at the NRC-Canada in the field of proteomics technology and application. Daniel and his group are developing microbiome technologies to screen for the effects of drugs on individual microbiomes. He has authored over 180 peer-reviewed publications, has an H-index of 55, and has been cited over 14,000 times.